Since the beginning of 2023, and as of 28 February 2023, no MERS-CoV cases have been reported with date of onset in 2023 by health authorities worldwide or by the WHO.
This issue of the Communicable Disease Threats Report (CDTR) covers the period 30 January - 5 February 2023 and includes updates on COVID-19, diphtheriae, mpox, influenza, influenza A (H9N2), influenza (H5N6), MERS-CoV, avian influenza, BSE, and Niaph virus.
Since April 2012, and as of 30 January 2023, a total of 2 613 cases of MERS-CoV, including 945 deaths, have been
reported by health authorities worldwide.
Chikungunya is not endemic in the EU/EEA and the majority of the cases are travellers infected outside of the EU/EEA. When the environmental conditions are favourable, in areas where Ae. albopictus is established, viraemic travel-related cases may generate a local transmission of the virus as demonstrated by the sporadic events of chikungunya virus transmission since 2007.
This issue of the Communicable Disease Threats Report (CDTR) covers the period 23-29 January 2023 and includes updates on COVID-19, diphtheriae, influenza, chikungunya, dengue and poliomyelitis.
Since April 2012, and as of 9 January 2023, a total of 2 610 cases of MERS-CoV, including 945 deaths, have been reported by health authorities worldwide.
Since the beginning of 2023, and as of 30 January 2023, no MERS-CoV cases have been reported with
date of onset in 2023 by health authorities worldwide or by the World Health Organization.
This issue of the CDTR covers the period 18-24 December 2022 and includes updates on chikungunya, cholera, COVID-19, dengue, C. diphtheriae, Ebola, influenza A(H5N1), Influenza A(H9N2), mass gathering monitoring, Mpox, swine influenza.